Delivery Order SPE2DX22D0020-SPE2D826F16PH
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,908.34 on January 12, 2026, by the Defense Logistics Agency's Medical Supply Chain. The contract, which is non-set-aside and competitively awarded, operates under a firm fixed-price arrangement with an ultimate completion date of January 13, 2026. This delivery order represents a task order under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $25,666.14 by the Defense Logistics Agency's Medical Supply Chain on January 8, 2026, with an ultimate completion date of January 9, 2026. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The parent...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $7,126.93 by the Defense Logistics Agency's Medical Supply Chain on June 16, 2025, with an ultimate completion date of June 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $49,902.34 by the Defense Logistics Agency's Medical Supply Chain with an ultimate completion date of February 3, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation, reflecting the contractor's ability to compete on a full and open basis for federal procurement requirements. The delivery order is issued...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $17,895.90 on February 2, 2026, with an ultimate completion date of February 3, 2026. This competitively awarded, firm fixed-price contract was issued by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency responsible for pharmaceutical and medical supply procurement for military and veteran healthcare systems. The...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $5,481.76 from the Defense Logistics Agency's Medical Supply Chain on February 2, 2026. This firm fixed-price contract, awarded competitively without set-aside restrictions, is scheduled for completion by February 3, 2026. The award represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $200,466 on January 13, 2026, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price, non-set-aside contract is scheduled for completion by January 14, 2026, and represents a task order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,646.92 by the Defense Logistics Agency's Medical Supply Chain on July 14, 2025, with an ultimate completion date of July 15, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which is valued at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,640.00 by the Defense Logistics Agency's Medical Supply Chain on January 29, 2026. This firm fixed-price contract, which is not set-aside and has an ultimate completion date of January 30, 2026, represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,927.48 on January 19, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside delivery order is scheduled for completion by January 20, 2026, and represents a task order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. AmerisourceBergen Drug Corp, a...
- SPE2DX22D0020Indefinite Delivery Contract
- SPE2DX22D0020-SPE2D826F16PHDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,363.88 on February 3, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside contract is scheduled for ultimate completion on February 4, 2026, and represents a task order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The IDC, designated SPE2DX and valued at $999,999,999.00 through December 2026, serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply pharmaceutical products and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), which holds the master IDC with the Defense Logistics Agency. Through this contract vehicle, the company delivers a vast range of critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and medical test kits to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The company's demonstrated capability to fulfill federal procurement requirements through open competition, combined with its established relationship with DLA, positions it as a key vendor for the Defense Logistics Agency's pharmaceutical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 2/2/26 |